Global In-Situ Hybridization Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

In Situ Hybridization (ISH)

Scope of the Report:
In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of gene expression. The technique is particularly useful in neuroscience.
The worldwide market for In-Situ Hybridization is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
This report focuses on the In-Situ Hybridization in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Radioactive isotopes
Non-radioactive labels

Market Segment by Applications, can be divided into
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases

There are 15 Chapters to deeply display the global In-Situ Hybridization market.
Chapter 1, to describe In-Situ Hybridization Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of In-Situ Hybridization, with sales, revenue, and price of In-Situ Hybridization, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of In-Situ Hybridization, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, In-Situ Hybridization market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe In-Situ Hybridization sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions